Bausch & Lomb, Gland Settle Patent Suit Over Generic Eye Drops

Bausch & Lomb Corp. and Nicox SA settled their federal lawsuit that alleged Gland Pharma Ltd.'s generic version of Vyzulta infringes four patents for the intraocular pressure-reducing eye drops.

Gland, a unit of Shanghai Fosun Pharmaceutical Group Co., will be blocked from selling its Vyzulta copies until US Patent Nos. 7,273,946, 7,629,345, 7,910,767, and 8,058,467 expire, “except as specifically authorized pursuant to the settlement agreement, under a consent judgment and injunction approved Wednesday by Judge Robert Kirsch in the US District Court for the District of New Jersey. It was the first patent-infringement case filed by ...